Annual CAPEX
$1.31 M
+$704.00 K+116.36%
31 December 2023
Summary:
Aclaris Therapeutics annual capital expenditures is currently $1.31 million, with the most recent change of +$704.00 thousand (+116.36%) on 31 December 2023. During the last 3 years, it has risen by +$856.00 thousand (+188.96%). ACRS annual CAPEX is now -18.85% below its all-time high of $1.61 million, reached on 31 December 2019.ACRS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$0.00
+$14.00 K+100.00%
30 September 2024
Summary:
Aclaris Therapeutics quarterly capital expenditures is currently $0.00, with the most recent change of +$14.00 thousand (+100.00%) on 30 September 2024. Over the past year, it has dropped by -$84.00 thousand (-100.00%). ACRS quarterly CAPEX is now -100.00% below its all-time high of $822.00 thousand, reached on 30 September 2019.ACRS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$562.00 K
-$84.00 K-13.00%
30 September 2024
Summary:
Aclaris Therapeutics TTM capital expenditures is currently $562.00 thousand, with the most recent change of -$84.00 thousand (-13.00%) on 30 September 2024. Over the past year, it has dropped by -$411.00 thousand (-42.24%). ACRS TTM CAPEX is now -68.55% below its all-time high of $1.79 million, reached on 30 September 2018.ACRS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRS CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +116.4% | -100.0% | -42.2% |
| 3 y3 years | +189.0% | -100.0% | +384.5% |
| 5 y5 years | -3.5% | -100.0% | -62.4% |
ACRS CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +325.0% | -100.0% | +100.0% | -57.1% | +384.5% |
| 5 y | 5 years | -18.9% | +325.0% | -100.0% | +100.0% | -65.2% | +384.5% |
| alltime | all time | -18.9% | +325.0% | -100.0% | +100.0% | -68.5% | +384.5% |
Aclaris Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | $562.00 K(-13.0%) |
| June 2024 | - | -$14.00 K(-110.4%) | $646.00 K(-27.5%) |
| Mar 2024 | - | $135.00 K(-69.4%) | $891.00 K(-31.9%) |
| Dec 2023 | $1.31 M(+116.4%) | $441.00 K(+425.0%) | $1.31 M(+34.5%) |
| Sept 2023 | - | $84.00 K(-63.6%) | $973.00 K(-6.4%) |
| June 2023 | - | $231.00 K(-58.2%) | $1.04 M(+4.5%) |
| Mar 2023 | - | $553.00 K(+426.7%) | $994.00 K(+64.3%) |
| Dec 2022 | $605.00 K(+96.4%) | $105.00 K(-30.0%) | $605.00 K(-13.6%) |
| Sept 2022 | - | $150.00 K(-19.4%) | $700.00 K(+15.5%) |
| June 2022 | - | $186.00 K(+13.4%) | $606.00 K(+28.4%) |
| Mar 2022 | - | $164.00 K(-18.0%) | $472.00 K(+53.2%) |
| Dec 2021 | $308.00 K(-32.0%) | $200.00 K(+257.1%) | $308.00 K(+165.5%) |
| Sept 2021 | - | $56.00 K(+7.7%) | $116.00 K(-68.1%) |
| June 2021 | - | $52.00 K(+550.0%) | $364.00 K(-19.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $453.00 K(-71.9%) | $8000.00(-97.4%) | $453.00 K(-36.3%) |
| Sept 2020 | - | $304.00 K(+1688.2%) | $711.00 K(-42.1%) |
| June 2020 | - | $17.00 K(-86.3%) | $1.23 M(-15.4%) |
| Mar 2020 | - | $124.00 K(-53.4%) | $1.45 M(-9.9%) |
| Dec 2019 | $1.61 M(+19.0%) | $266.00 K(-67.6%) | $1.61 M(+8.0%) |
| Sept 2019 | - | $822.00 K(+241.1%) | $1.49 M(+21.3%) |
| June 2019 | - | $241.00 K(-15.1%) | $1.23 M(-8.3%) |
| Mar 2019 | - | $284.00 K(+94.5%) | $1.34 M(-1.0%) |
| Dec 2018 | $1.36 M(+9.8%) | $146.00 K(-73.9%) | $1.36 M(-24.1%) |
| Sept 2018 | - | $560.00 K(+59.1%) | $1.79 M(+19.4%) |
| June 2018 | - | $352.00 K(+18.1%) | $1.50 M(+30.7%) |
| Mar 2018 | - | $298.00 K(-48.4%) | $1.15 M(+35.2%) |
| Dec 2017 | $1.24 M | $577.00 K(+113.7%) | $847.00 K(+213.7%) |
| Sept 2017 | - | $270.00 K | $270.00 K |
FAQ
- What is Aclaris Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual CAPEX year-on-year change?
- What is Aclaris Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly CAPEX year-on-year change?
- What is Aclaris Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Aclaris Therapeutics?
- What is Aclaris Therapeutics TTM CAPEX year-on-year change?
What is Aclaris Therapeutics annual capital expenditures?
The current annual CAPEX of ACRS is $1.31 M
What is the all time high annual CAPEX for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual capital expenditures is $1.61 M
What is Aclaris Therapeutics annual CAPEX year-on-year change?
Over the past year, ACRS annual capital expenditures has changed by +$704.00 K (+116.36%)
What is Aclaris Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of ACRS is $0.00
What is the all time high quarterly CAPEX for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly capital expenditures is $822.00 K
What is Aclaris Therapeutics quarterly CAPEX year-on-year change?
Over the past year, ACRS quarterly capital expenditures has changed by -$84.00 K (-100.00%)
What is Aclaris Therapeutics TTM capital expenditures?
The current TTM CAPEX of ACRS is $562.00 K
What is the all time high TTM CAPEX for Aclaris Therapeutics?
Aclaris Therapeutics all-time high TTM capital expenditures is $1.79 M
What is Aclaris Therapeutics TTM CAPEX year-on-year change?
Over the past year, ACRS TTM capital expenditures has changed by -$411.00 K (-42.24%)